FDA Recalls Hydromorphone Syringes Due to Sterility Concerns
Banner Pharmacy Services is recalling specific lots of Hydromorphone HCl syringes because the FDA determined there is a lack of assurance of sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a significant risk of harm (lack of sterility in an injectable drug) is categorized as Severe.
Plain-English summary
Banner Pharmacy Services, LLC is recalling 1,658 syringes of Hydromorphone HCl 10 mg (0.2mg/ml) in 0.9% Sodium Chloride. The recall was initiated because the U.S. Food and Drug Administration determined there is a lack of assurance of sterility for the product.
The affected product is identified by NDC 7025001001 and was distributed nationwide within the United States. The recall covers specific lots with expiration dates ranging from October 15, 2017, to February 1, 2018. The source text does not specify the exact number of units distributed to individual facilities or the specific states affected beyond the nationwide scope.
Consumers and healthcare providers should stop using the recalled syringes and contact their pharmacist or Banner Pharmacy Services for further instructions. The FDA classifies this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Hydromorphone HCl 10 mg (0.2mg/ml) 50 mL syringes in 0.9% Sodium Chloride, Rx Only, Banner Health Compounding Pharmacy 7300 W Detroit St Chandler, AZ 95226, NDC 7025001001.
- Manufacturer
- Banner Pharmacy Services, LLC
- Category
- Drug — Injectable
- Hazard
- Affected units
- 1,658
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot #: 041817S5
- Exp 10/15/2017
- 052417S2
- Exp 11/20/2017
- 071117S4
- Exp 1/7/2018
- 0712217S4
- Exp 1/8/2018
- 080317S6
- Exp 1/30/2018
- 082217S5
- Exp 2/1/2018
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 14 recalled by Banner Pharmacy Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Banner Pharmacy Services, LLC
See all →- SevereBanner Pharmacy Recalls Fentanyl Citrate Syringes Due to Sterility Concerns
FDA (Drugs) · 2017-11-01
- SevereBanner Pharmacy Recalls Oxytocin Infusion Bags Due to Sterility Concerns
FDA (Drugs) · 2017-11-01
- SevereBanner Pharmacy Recalls Magnesium Sulfate IV Bags Due to Sterility Concerns
FDA (Drugs) · 2017-11-01
- SevereBanner Pharmacy Recalls Norepinephrine Bags Due to Sterility Concerns
FDA (Drugs) · 2017-11-01
- SevereBanner Health Recalls Vancomycin Bags Due to Sterility Concerns
FDA (Drugs) · 2017-11-01
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29